DBV Technologies SA - ADR
General ticker "DBVT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $197.0M
DBV Technologies SA - ADR does not follow the US Stock Market performance with the rate: -39.8%.
Estimated limits based on current volatility of 4.4%: low 2.95$, high 3.22$
Factors to consider:
- Current price 27.4% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.55$, 11.46$]
- 2024-12-30 to 2025-12-30 estimated range: [4.33$, 10.33$]
Financial Metrics affecting the DBVT estimates:
- Negative: Non-GAAP EPS, $ of -0.78 <= 0.10
- Negative: Operating profit margin, % of -82.93 <= 1.03
- Negative: Operating cash flow per share per price, % of -33.84 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term DBVT quotes
Long-term DBVT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 |
|---|---|---|
| Operating Revenue | $4.84MM | $15.73MM |
| Operating Expenses | $101.47MM | $92.16MM |
| Operating Income | $-96.63MM | $-76.43MM |
| Non-Operating Income | $0.43MM | $3.71MM |
| Interest Expense | $0.43MM | $0.00MM |
| R&D Expense | $75.50MM | $60.22MM |
| Income(Loss) | $-96.20MM | $-72.72MM |
| Taxes | $0.07MM | $0.01MM |
| Profit(Loss) | $-96.27MM | $-72.73MM |
| Stockholders Equity | $194.45MM | $140.19MM |
| Inventory | $11.20MM | $0.00MM |
| Assets | $246.52MM | $182.99MM |
| Operating Cash Flow | $-55.70MM | $-79.65MM |
| Capital expenditure | $0.75MM | $0.68MM |
| Investing Cash Flow | $-0.10MM | $-0.81MM |
| Financing Cash Flow | $194.10MM | $6.77MM |
| Earnings Per Share* | $-4.96 | $-2.84 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.